← Leaderboards
Richard C Boucher
University Of North Carolina Chapel Hill
$55,332,929
Attributed
$62,564,106
Total exposure
45
Grants
39
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$190,143,196 · 54
By mechanism
P01$93,494,341 · 25
P50$35,488,969 · 6
P30$29,551,010 · 11
R01$10,017,184 · 4
T32$8,911,054 · 2
UH3$4,648,925 · 1
Top collaborators
- Claire M Doerschuk15 shared
- Terry L Noah12 shared
- Michael Rubinstein8 shared
- David B Peden5 shared
- Gang Chen4 shared
- Sally E Wenzel4 shared
- Kenneth N. Olivier3 shared
- Stephanie Duggins Davis1 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Michael R Knowles$33,731,453
- David B Peden$24,843,616
- Scott H Randell$11,007,731
- Lawrence E Ostrowski$7,659,247
- Wanda K O'Neal$8,008,262
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCystic FibrosisMucous Body SubstanceLung DiseasesMucinsSurfaceProgramsIn VitroResearch PersonnelIn VivoPathogenesisBaseMolecularDesignNovel TherapeuticsChronic Obstructive Airway DiseaseHydration StatusResponsePropertyCystic Fibrosis Transmembrane Conductance RegulatorInflammationAsthmaChronicEpithelial Cells
Grant awards (200)
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease$2,754,776
P01 · FY2025 · HL · contact PI
Rare Bronchiectatic Diseases Consortium$1,425,304
U54 · FY2025 · HL
UNC Cystic Fibrosis Research and Translation Core Center$1,266,184
P30 · FY2025 · DK
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)$761,057
U01 · FY2025 · HL · contact PI
Rare Bronchiectatic Diseases Consortium$636,416
U54 · FY2025 · HL · contact PI
UNC Research Training Program in Respiratory Diseases and Critical Care$545,322
T32 · FY2025 · HL
Rare Bronchiectatic Diseases Consortium$50,819
U54 · FY2025 · HL
Rare Bronchiectatic Diseases Consortium$39,259
U54 · FY2025 · HL
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease$2,699,679
P01 · FY2024 · HL · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$1,166,250
P30 · FY2024 · DK · contact PI
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)$746,333
U01 · FY2024 · HL · contact PI
UNC Research Training Program in Respiratory Diseases and Critical Care$563,600
T32 · FY2024 · HL
Pilot & Feasibility Program$219,924
P30 · FY2024 · DK · contact PI
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease$88,718
P01 · FY2024 · HL · contact PI
Core A: Administrative Core$74,493
P30 · FY2024 · DK · contact PI
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease$2,757,565
P01 · FY2023 · HL · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$1,166,250
P30 · FY2023 · DK · contact PI
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)$734,207
U01 · FY2023 · HL · contact PI
Mucin sialylation drives epithelial cell senescence and severe asthma$695,513
R01 · FY2023 · HL
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?$552,963
P01 · FY2023 · HL · contact PI
UNC Research Training Program in Respiratory Diseases and Critical Care$526,943
T32 · FY2023 · HL
Pilot & Feasibility Program$219,924
P30 · FY2023 · DK · contact PI
Core A: Administrative/Biostatistics Core$191,016
P01 · FY2023 · HL · contact PI
Diversity Supplement for PhD student Shamarie King under Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease$102,593
P01 · FY2023 · HL · contact PI
Core A: Administrative Core$74,493
P30 · FY2023 · DK · contact PI
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease$2,769,140
P01 · FY2022 · HL · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$1,166,250
P30 · FY2022 · DK · contact PI
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)$748,549
U01 · FY2022 · HL · contact PI
Mucin sialylation drives epithelial cell senescence and severe asthma$695,967
R01 · FY2022 · HL
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?$552,963
P01 · FY2022 · HL · contact PI
Pilot & Feasibility Program$219,924
P30 · FY2022 · DK · contact PI
Core A: Administrative/Biostatistics Core$188,227
P01 · FY2022 · HL · contact PI
Core A: Administrative Core$74,493
P30 · FY2022 · DK · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,173,966
P01 · FY2021 · HL
UNC Cystic Fibrosis Research and Translation Core Center$1,166,250
P30 · FY2021 · DK · contact PI
Mucin sialylation drives epithelial cell senescence and severe asthma$689,996
R01 · FY2021 · HL
Project 2: PK/PD requirements for mucolytic therapeutic agents in vitro and in vivo$422,943
P01 · FY2021 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$254,790
T32 · FY2021 · HL
Pilot & Feasibility Program$219,924
P30 · FY2021 · DK · contact PI
Core A: Program Management and Biostatistics Core$193,709
P01 · FY2021 · HL · contact PI
Core A: Administrative Core$74,493
P30 · FY2021 · DK · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,173,973
P01 · FY2020 · HL
UNC Cystic Fibrosis Research and Translation Core Center$1,216,075
P30 · FY2020 · DK · contact PI
Mucin sialylation drives epithelial cell senescence and severe asthma$746,830
R01 · FY2020 · HL
Multiscale Biochemical/Biophysical Integration of Pulmonary Mucus Transport$646,802
R01 · FY2020 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$499,146
T32 · FY2020 · HL
Project 2: PK/PD requirements for mucolytic therapeutic agents in vitro and in vivo$478,046
P01 · FY2020 · HL · contact PI
Core A: Program Management and Biostatistics Core$213,434
P01 · FY2020 · HL · contact PI
Core A: Administrative Core$202,680
P30 · FY2020 · DK · contact PI
Pilot & Feasibility Program$202,679
P30 · FY2020 · DK · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$1,826,101
P01 · FY2019 · HL
UNC Cystic Fibrosis Research and Translation Core Center$1,139,998
P30 · FY2019 · DK · contact PI
Multiscale Biochemical/Biophysical Integration of Pulmonary Mucus Transport$646,802
R01 · FY2019 · HL · contact PI
Project 2: PK/PD requirements for mucolytic therapeutic agents in vitro and in vivo$400,546
P01 · FY2019 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$305,275
T32 · FY2019 · HL
Pilot and Feasibility Program$224,482
P30 · FY2019 · DK · contact PI
Core A: Program Management and Biostatistics Core$135,934
P01 · FY2019 · HL · contact PI
Administrative Core$93,641
P30 · FY2019 · DK · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,446,101
P01 · FY2018 · HL
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease$1,601,773
UH3 · FY2018 · HL · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$1,139,998
P30 · FY2018 · DK · contact PI
Multiscale Biochemical/Biophysical Integration of Pulmonary Mucus Transport$646,802
R01 · FY2018 · HL · contact PI
Project 2: PK/PD requirements for mucolytic therapeutic agents in vitro and in vivo$478,046
P01 · FY2018 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$458,296
T32 · FY2018 · HL
Pilot and Feasibility Program$223,346
P30 · FY2018 · DK · contact PI
Core A: Program Management and Biostatistics Core$213,434
P01 · FY2018 · HL · contact PI
Administrative Core$94,779
P30 · FY2018 · DK · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,452,224
P01 · FY2017 · HL
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease$1,525,115
UH3 · FY2017 · HL · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$1,139,998
P30 · FY2017 · DK · contact PI
Multiscale Biochemical/Biophysical Integration of Pulmonary Mucus Transport$646,802
R01 · FY2017 · HL · contact PI
Multiscale Biochemical/Biophysical Integration of Pulmonary Mucus Transport$615,179
R01 · FY2017 · HL · contact PI
Project 2: PK/PD requirements for mucolytic therapeutic agents in vitro and in vivo$517,529
P01 · FY2017 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$344,999
T32 · FY2017 · HL
Administrative Core$250,000
P30 · FY2017 · DK · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$250,000
P30 · FY2017 · DK · contact PI
Pilot and Feasibility Program$227,052
P30 · FY2017 · DK · contact PI
Core A: Program Management and Biostatistics Core$221,405
P01 · FY2017 · HL · contact PI
Administrative Core$84,200
P30 · FY2017 · DK · contact PI
Novel Therapies for Muco-Obstructive Lung Diseases$2,622,030
P01 · FY2016 · HL · contact PI
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease$1,522,037
UH3 · FY2016 · HL · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$1,139,998
P30 · FY2016 · DK · contact PI
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia$491,435
P01 · FY2016 · HL · contact PI
Mucus Obstructed Mice for Biomarker and Drug Development$485,248
P01 · FY2016 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$442,058
T32 · FY2016 · HL
Mechanisms and Consequences of Nucleotide Release in the Lung$423,776
P01 · FY2016 · HL · contact PI
: CFTR-ENaC Regulatory and Structural Interactions in Human Airway Epithelia$409,767
P01 · FY2016 · HL · contact PI
Dynamics and Thermal Stability in CFTR Function and Dysfunction$368,331
P01 · FY2016 · HL · contact PI
Pilot and Feasibility Program$223,346
P30 · FY2016 · DK · contact PI
Molecular Biology Core$220,561
P01 · FY2016 · HL · contact PI
Cell Culture Core$128,981
P01 · FY2016 · HL · contact PI
Administrative Core$118,000
P01 · FY2016 · HL · contact PI
Administrative Core$110,720
P01 · FY2016 · HL · contact PI
Administrative Core$94,779
P30 · FY2016 · DK · contact PI
Novel Therapies for Muco-Obstructive Lung Diseases$2,585,676
P01 · FY2015 · HL · contact PI
Pulmonary Surface Liquid Homeostasis$2,121,268
P01 · FY2015 · HL · contact PI
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease$1,424,781
UH2 · FY2015 · HL · contact PI
UNC Cystic Fibrosis Research and Translation Core Center$1,139,998
P30 · FY2015 · DK · contact PI
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia$486,820
P01 · FY2015 · HL · contact PI
Mucus Obstructed Mice for Biomarker and Drug Development$480,885
P01 · FY2015 · HL · contact PI
Mechanisms and Consequences of Nucleotide Release in the Lung$419,161
P01 · FY2015 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$415,477
T32 · FY2015 · HL
: CFTR-ENaC Regulatory and Structural Interactions in Human Airway Epithelia$405,152
P01 · FY2015 · HL · contact PI
Dynamics and Thermal Stability in CFTR Function and Dysfunction$363,717
P01 · FY2015 · HL · contact PI
Molecular Biology Core$215,946
P01 · FY2015 · HL · contact PI
Administrative Core$190,000
P30 · FY2015 · DK · contact PI
Pilot and Feasibility Program$189,998
P30 · FY2015 · DK · contact PI
Cell Culture Core$124,367
P01 · FY2015 · HL · contact PI
Administrative Core$113,214
P01 · FY2015 · HL · contact PI
Administrative Core$106,105
P01 · FY2015 · HL · contact PI
Novel Therapies for Muco-Obstructive Lung Diseases$2,575,240
P01 · FY2014 · HL · contact PI
Pulmonary Surface Liquid Homeostasis$2,110,500
P01 · FY2014 · HL · contact PI
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease$1,459,479
UH2 · FY2014 · HL · contact PI
Molecular Therapy Core Center$724,192
P30 · FY2014 · DK · contact PI
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia$481,607
P01 · FY2014 · HL · contact PI
Mucus Obstructed Mice for Biomarker and Drug Development$476,588
P01 · FY2014 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$421,918
T32 · FY2014 · HL
Mechanisms and Consequences of Nucleotide Release in the Lung$415,301
P01 · FY2014 · HL · contact PI
: CFTR-ENaC Regulatory and Structural Interactions in Human Airway Epithelia$401,573
P01 · FY2014 · HL · contact PI
Dynamics and Thermal Stability in CFTR Function and Dysfunction$360,966
P01 · FY2014 · HL · contact PI
Molecular Biology Core$216,149
P01 · FY2014 · HL · contact PI
Cell Culture Core$126,400
P01 · FY2014 · HL · contact PI
Administrative Core$115,894
P01 · FY2014 · HL · contact PI
Administrative Core$108,504
P01 · FY2014 · HL · contact PI
Pulmonary Surface Liquid Homeostasis$100,000
P01 · FY2014 · HL · contact PI
Administrative Core$42,472
P30 · FY2014 · DK · contact PI
Novel Therapies for Muco-Obstructive Lung Diseases$41,786
P01 · FY2014 · HL · contact PI
Novel Therapies for Muco-Obstructive Lung Diseases$2,423,706
P01 · FY2013 · HL · contact PI
Pulmonary Surface Liquid Homeostasis$2,050,200
P01 · FY2013 · HL · contact PI
Molecular Therapy Core Center$948,967
P30 · FY2013 · DK · contact PI
The Role of Anaerobic Bacterial Infection in Cystic Fibrosis$684,379
R01 · FY2013 · HL · contact PI
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia$467,848
P01 · FY2013 · HL · contact PI
Mucus Obstructed Mice for Biomarker and Drug Development$448,545
P01 · FY2013 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$413,326
T32 · FY2013 · HL
Mechanisms and Consequences of Nucleotide Release in the Lung$403,434
P01 · FY2013 · HL · contact PI
: CFTR-ENaC Regulatory and Structural Interactions in Human Airway Epithelia$390,100
P01 · FY2013 · HL · contact PI
Dynamics and Thermal Stability in CFTR Function and Dysfunction$350,653
P01 · FY2013 · HL · contact PI
Administrative Core$245,313
P30 · FY2013 · DK · contact PI
Molecular Biology Core$209,972
P01 · FY2013 · HL · contact PI
Cell Culture Core$122,788
P01 · FY2013 · HL · contact PI
Administrative Core$109,074
P01 · FY2013 · HL · contact PI
Administrative$105,405
P01 · FY2013 · HL · contact PI
Novel Therapies for Muco-Obstructive Lung Diseases$2,545,908
P01 · FY2012 · HL · contact PI
Pulmonary Surface Liquid Homeostasis$2,153,571
P01 · FY2012 · HL · contact PI
Molecular Therapy Core Center$1,021,397
P30 · FY2012 · DK · contact PI
The Role of Anaerobic Bacterial Infection in Cystic Fibrosis$721,362
R01 · FY2012 · HL · contact PI
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia$491,435
P01 · FY2012 · HL · contact PI
Mucus Obstructed Mice for Biomarker and Drug Development$471,159
P01 · FY2012 · HL · contact PI
Mucus Adhesion to Epithelial Cells and its Mobilization in COPD and CF$442,662
P50 · FY2012 · HL · contact PI
Multidisciplinary research training in pulmonary diseases$406,452
T32 · FY2012 · HL
Administrative Core$268,519
P30 · FY2012 · DK · contact PI
Administrative Core$114,574
P01 · FY2012 · HL · contact PI
Administrative$110,720
P01 · FY2012 · HL · contact PI
Pulmonary Epithelia in Health and Disease$1,893,908
P01 · FY2011 · HL · contact PI
Molecular Therapy Core Center$1,036,000
P30 · FY2011 · DK · contact PI
The Role of Anaerobic Bacterial Infection in Cystic Fibrosis$726,233
R01 · FY2011 · HL · contact PI
The Role of Airway Surface Liquid Nucleotides/Nucleosides in Volume Homeostasis$496,411
P01 · FY2011 · HL · contact PI
Mucus Adhesion to Epithelial Cells and its Mobilization in COPD and CF$442,662
P50 · FY2011 · HL · contact PI
PULMONARY, CRITICAL CARE, AND MOLECULAR TRAINING$313,728
T32 · FY2011 · HL · contact PI
Administrative Core$272,357
P30 · FY2011 · DK · contact PI
Administrative$116,146
P01 · FY2011 · HL · contact PI
SCCOR in Host Factors in Chronic Lung Disease$3,373,312
P50 · FY2010 · HL · contact PI
Pulmonary Epithelia in Health and Disease$1,893,908
P01 · FY2010 · HL · contact PI
Molecular Therapy Core Center$1,036,000
P30 · FY2010 · DK · contact PI
The Role of Anaerobic Bacterial Infection in Cystic Fibrosis$740,568
R01 · FY2010 · HL · contact PI
The Role of Airway Surface Liquid Nucleotides/Nucleosides in Volume Homeostasis$496,411
P01 · FY2010 · HL · contact PI
Mucus Dehydration and Evolution of COPD Lung Disease$465,269
P50 · FY2010 · HL · contact PI
Administrative and Biostatistics Core$440,352
P50 · FY2010 · HL · contact PI
PULMONARY, CRITICAL CARE, AND MOLECULAR TRAINING$319,114
T32 · FY2010 · HL · contact PI
Administrative Core$272,357
P30 · FY2010 · DK · contact PI
Administrative$116,146
P01 · FY2010 · HL · contact PI
SCCOR in Host Factors in Chronic Lung Disease$3,273,022
P50 · FY2009 · HL · contact PI
Pulmonary Epithelia in Health and Disease$1,893,908
P01 · FY2009 · HL · contact PI
Molecular Therapy Core Center$1,035,125
P30 · FY2009 · DK · contact PI
The Role of Airway Surface Liquid Nucleotides/Nucleosides in Volume Homeostasis$496,411
P01 · FY2009 · HL · contact PI
Mucus Dehydration and Evolution of COPD Lung Disease$482,039
P50 · FY2009 · HL · contact PI
PULMONARY, CRITICAL CARE, AND MOLECULAR TRAINING$366,029
T32 · FY2009 · HL · contact PI
Administrative and Biostatistics Core$363,458
P50 · FY2009 · HL · contact PI
Administrative Core$303,071
P30 · FY2009 · DK · contact PI
Molecular Therapy Core Center$148,000
P30 · FY2009 · DK · contact PI
Molecular Therapy Core Center$117,714
P30 · FY2009 · DK · contact PI
Administrative$116,146
P01 · FY2009 · HL · contact PI
SCCOR in Host Factors in Chronic Lung Disease$3,111,178
P50 · FY2008 · HL · contact PI
Pulmonary Epithelia in Health and Disease$1,856,030
P01 · FY2008 · HL · contact PI
Molecular Therapy Core Center$962,591
P30 · FY2008 · DK · contact PI
Mucus Dehydration and Evolution of COPD Lung Disease$487,846
P50 · FY2008 · HL · contact PI
The Role of Airway Surface Liquid Nucleotides/Nucleosides in Volume Homeostasis$486,468
P01 · FY2008 · HL · contact PI
PULMONARY, CRITICAL CARE, AND MOLECULAR TRAINING$362,971
T32 · FY2008 · HL · contact PI
Administrative and Biostatistics Core$303,425
P50 · FY2008 · HL · contact PI
Administrative$113,834
P01 · FY2008 · HL · contact PI
CLINICAL TRIAL: MUCUS CLEARANCE AND EVOLUTION OF COPD LUNG DISEASE$5,509
M01 · FY2008 · RR · contact PI
SCCOR in Host Factors in Chronic Lung Disease$2,926,850
P50 · FY2007 · HL · contact PI
Pulmonary Epithelia in Health and Disease$1,893,908
P01 · FY2007 · HL · contact PI
SCOR in Airway Biology/Pathogenesis of Cystic Fibrosis$1,823,780
P50 · FY2007 · HL · contact PI
Molecular Therapy Core Center$962,591
P30 · FY2007 · DK · contact PI
The Role of Airway Surface Liquid Nucleotides/Nucleosides in Volume Homeostasis$496,412
P01 · FY2007 · HL · contact PI
Mucus Dehydration and Evolution of COPD Lung Disease$371,667
P50 · FY2007 · HL · contact PI
THE BIOLOGY OF MUCUS AND MUCUS PLAQUES ON CF AIRWAYS$364,120
P50 · FY2007 · HL · contact PI
PULMONARY, CRITICAL CARE, AND MOLECULAR TRAINING$362,971
T32 · FY2007 · HL · contact PI
Administrative and Biostatistics Core$294,799
P50 · FY2007 · HL · contact PI